| Wed 16 Feb 2011, 10:43 | | LHG - Litha Healthcare Group Limited - Change to the board of directors |
|
LHG
LHG
LHG - Litha Healthcare Group Limited - Change to the board of directors
LITHA HEALTHCARE GROUP LIMITED
(Formerly Myriad Medical Holdings Limited)
Incorporated in the Republic of South Africa
(Registration number 2006/006371/06)
Share code: LHG, ISIN: ZAE000144671
("Litha" or "the company")
CHANGE TO THE BOARD OF DIRECTORS
Shareholders are advised that Mr Ian Jacobson has been appointed to Litha`s
board of directors as a non-executive director, with immediate effect.
A former South African, Ian heads up CPOINT CAPITAL INC., a Canadian based
company, prior to which Ian held the position of CEO of Cobalt Pharmaceuticals,
an Arrow Group company, overseeing $300 million in sales. The Arrow Group was
sold in 2009 to Watson Pharmaceuticals. Prior to his tenure at Arrow Group, Ian
was part of the executive team at Amerpharm, serving in various positions,
including Executive Vice President at Genpharm (in Canada). Amerpharm was sold
to Merck KGaA in 1996.
With over 30 years` experience in the pharmaceutical industry, specialising in
operations, business development and sales and marketing, Ian has succeeded in a
number of high profile positions at various companies around the globe,
including the USA, Canada, Europe, and South Africa.
16 February 2011
Sponsor
Java Capital
Date: 16/02/2011 10:43:01 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
